Banning the Box Would Help People Released From Prison Rebuild Their Lives
Michael Leo Owens, The Conversation; Posted Aug 3, 10:17 p.m. ET
Many of those who have been imprisoned have weak ties to mainstream employment and limited skills. But a low barrier trips up a lot of them -- the question on job applications asking people to disclose criminal convictions (and sometimes arrests).
Flow Chart for Accessing PrEP for HIV Prevention
Project Inform; Posted Aug 3, 9:46 p.m. ET
Project Inform has created a new flow chart for both consumers and health navigators to use for accessing services and covering costs related to PrEP.
Dispersible Tablet Formulation of Dolutegravir Bioequivalent to the Granule Formulation
Polly Clayden, HIV i-Base; Posted Aug 3, 5:09 p.m. ET
A dispersible tablet formulation of dolutegravir (Tivicay, DTG) has been developed as an alternative to the granule formulation for infants and young children. Pharmacokinetic data presented at IAS 2015 showed the tablet and granule formulations are bioequivalent.
Tribute to Bob Munk: Long-Time HIV-Positive U.S. Treatment Activist and Educator
Simon Collins and Polly Clayden, HIV i-Base; Posted Aug 3, 5:04 p.m. ET
It was with great sadness that in the week before IAS 2015 we learned of the death of Robert Munk, a long-time U.S. activist, friend and colleague.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
PrEP, Earlier ART and Better HIV Care in the Updated National HIV/AIDS Strategy
Emily Newman, BETA; Posted Aug 3, 4:34 p.m. ET
The National HIV/AIDS Strategy has just undergone a makeover. San Francisco's BETA Blog has a breakdown of its biggest recommendations for HIV care in the U.S.
Advocates Say Mental Health Parity Law Is Not Fulfilling Its Promise
Jenny Gold, Kaiser Health News; Posted Aug 3, 3:41 p.m. ET
Seven years ago, Congress passed a landmark law banning discrimination in mental health care access. Today, many families and their advocates say it persists, because insurers are subverting the law and the government is not aggressively enforcing it.
A Trans Man Discusses PrEP and Condomless Casual Sex
Brandyn Gallagher, TheBody.com; Posted Aug 3, 2:50 p.m. ET
When it comes to PrEP, condoms and sex, how can you make a well-informed, rational decision when researchers won't study your community? Brandyn Gallagher, a transgender man, writes about his experiences at the nexus of these issues.
Revisiting HIV Prevention Messaging to Reach Those Who Are Undiagnosed
James Wilton, Canadian AIDS Treatment Information Exchange; Posted Aug 3, 2:39 p.m. ET
How do change HIV prevention messaging to reach those people who don't yet know their HIV status?
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
What's the Next Big Question in HIV Treatment?
Myles Helfand, TheBodyPRO.com; Posted Jul 31, 4:04 p.m. ET
Now that a major study has concluded that the benefits of starting treatment immediately far outweighs the risks of delaying for all individuals living with HIV -- what's the next big question researchers should try to answer about HIV treatment?
Are U.S. Vaccine Rates Going Down Because Public Trust and Social Ties Are Eroding?
Charles McCoy, The Conversation; Posted Jul 31, 1:13 p.m. ET
Vaccines have been used safely and effectively for decades. So why is the American public -- or at least a significant segment of it -- now increasingly skeptical of mandatory school vaccinations?
Four Challenges We Have to Crack Before Immune Therapy Can Revolutionize How We Fight Cancer
Sri Krishna, The Conversation; Posted Jul 31, 12:57 p.m. ET
Within the last five years, a new class of drugs that uses our immune systems to fight cancer is gaining traction in cancer treatment. This is called "immunotherapy." Instead of killing cancer cells with radiation or chemotherapy, immunotherapy mobilizes the immune system to fight against cancer much like it does against bacteria and viruses.
CRISPR/Cas Gene-Editing Technique Holds Great Promise, but Research Moratorium Makes Sense Pending Further Study
Jeff Bessen, The Conversation; Posted Jul 31, 12:31 p.m. ET
CRISPR/Cas is a new technology that allows unprecedented control over the DNA code. It's sparked a revolution in the fields of genetics and cell biology, becoming the scientific equivalent of a household name by raising hopes about new ways to cure diseases.
>> Browse Older Featured Stories